SWITCHING TO TENOFOVIR ALAFENAMIDE IN HBV: NATIONWIDE REAL LIFE DATA OF EFFICACY AND SAFETY FROM TURKEY
dc.authorid | Yildiz, İlknur Esen/0000-0003-2987-0483 | |
dc.authorid | Karabay, Oguz/0000-0003-1514-1685 | |
dc.authorwosid | Yildiz, İlknur Esen/AAR-3407-2021 | |
dc.authorwosid | Karabay, Oguz/HHN-5893-2022 | |
dc.contributor.author | Tabak, Fehmi | |
dc.contributor.author | Yoruk, Gulsen | |
dc.contributor.author | Koksal, Iftihar | |
dc.contributor.author | Erdem, Hazal | |
dc.contributor.author | Yildiz, Dilek | |
dc.contributor.author | Ince, Nevin | |
dc.contributor.author | Yamazhan, Tansu | |
dc.date.accessioned | 2023-01-12T20:22:17Z | |
dc.date.available | 2023-01-12T20:22:17Z | |
dc.date.issued | 2021 | |
dc.department | N/A/Department | en_US |
dc.description.abstract | [No Abstract Available] | en_US |
dc.identifier.endpage | 498A | en_US |
dc.identifier.issn | 0270-9139 | |
dc.identifier.issn | 1527-3350 | |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.issn | 1527-3350 | en_US |
dc.identifier.startpage | 497A | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/79384 | |
dc.identifier.volume | 74 | en_US |
dc.identifier.wos | WOS:000707188002220 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | SWITCHING TO TENOFOVIR ALAFENAMIDE IN HBV: NATIONWIDE REAL LIFE DATA OF EFFICACY AND SAFETY FROM TURKEY | en_US |
dc.type | Conference Object | en_US |